Conference Reports for NATAP
The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
Back
Exposure to tenofovir alafenamide and tenofovir disoproxil fumarate and the risk of hepatocellular carcinoma
AASLD 2025 Nov 7-11 Wash DC
W. Ray Kim,1
